Reproductive Blueprint

Slides:



Advertisements
Similar presentations
Department of Reproductive Medicine UCSD School of Medicine
Advertisements

1 Female Reproductive Disorders. 2 Problems Related to Menstruation Premenstrual Syndrome Dysmenorrhea Oligomenorrhea Amenorrhea Menorrhagia Metrorrhagia.
Abnormal uterine bleeding King Khalid University Hospital Department of Obstetrics & Gynecology Course 481 Tutorials.
Valerie Robinson D.O.. Dysmenorrhea – painful menstruation Symptoms – Recurrent episodes of uterine cramps and lower abdominal pain during menstrual cycle.
Pelvic Pain Mr James Campbell.
Abnormal uterine bleeding
DYSFUNCTIONAL UTERINE BLEEDING
Endometrium Dr. Raid Jastania.
Endometrial Cancer Screening for Cancer in Women.
District 1 ACOG Medical Student Teaching Module 2009
Endometrial Hyperplasia
Post Menopausal Bleeding
,, Presence of functioning endometrial glands and stroma outside their usual location ( the uterine cavity) ”.
UTERINE FIBROIDS Hazem Al-Mandeel, M.D Course 481 Obstetrics and Gynecology Rotation.
Women’s Hospital, School of Medicine Zhejiang University Prof. Lin Jun
Infertility In Women Lesson 2.
Polycystic Ovarian Disease and Endometriosis
Reproductive health. Cancer Definition Cancer Definition The abnormal growth of cells without normal control of body. Types of Cancer  Malignant Cancer.
ASSOCIATE PROFESSOR IOLANDA BLIDARU
Recurrence of Leiomyomata (cont’d) Indeed, between 10% and 25% of women undergoing myomectomies require another surgical procedure within the next decade.
 The term post menopause is applied to women who have not experienced a menstrual bleed for a minimum of 12 months, assuming that they do still have.
 Not being able to get pregnant  Common causes for females:  Fallopian tube blockage  Ovulation disorders  Polycystic ovary syndrome  endometriosis.
Abnormal Uterine Bleeding
Academic Year MSIII Ob/Gyn Clerkship Self-Directed Study
( also called uterine Leiomyoma, Myoma, Myomata uteri, fibromyoma).
Post-menopausal bleeding PV Dr Nasira Sabiha Dawood.
Endometrial Carcinoma
POLYCYSTIC OVARIAN DISEASE AND ENDOMETRIOSIS Emad Raddaoui, MD, FCAP, FASC Associate Professor & Consultant 1.
In the Name of God. Abnormal perimenopausal and Postmenopausal Bleeding F.Behnamfar GYNECOLOGY ONCOLOGY FELLOWSHIP KASHAN UNIVERSITY OF MEDICAL SCIENCES.
Abnormal uterine bleeding King Khalid University Hospital Department of Obstetrics & Gynecology Course 481 Tutorials.
Endometrial Cancer By Jessica Hall. Symptoms Unusual vaginal bleeding or discharge Difficult or painful urination Pain during intercourse Pain in the.
DYSFUNCTIONAL UTERINE BLEEDING AHMED ABDULWAHAB. Definition. Definition. It is abnormal vaginal bleeding in the child bearing period where no organic.
Postmenopausal bleeding
UTERINE CORPUS. ACUTE ENDOMETRITIS Is most often related to intrauterine trauma from instrumentation, intrauterine contraceptive device or complications.
Vaginal Bleeding in the Perimenopause (Age 35-50)
DYSFUNCTIONAL UTERINE BLEEDING Gem Ashby MD OB/GYN.
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
ABNORMAL UTERINE BLEEDING
POLYCYSTIC OVARIAN DISEASE AND ENDOMETRIOSIS Emad Raddaoui, MD, FCAP, FASC Associate Professor & Consultant 1.
Endometriosis and Adenomyosis
Dr. Ahmed jasim Ass.Prof.MBChB-DOG-FICMS COSULTANT OF GYN. & OBST. COSULTANT OF GYN. & OBST.
1 UTERINE LEIOMYOMAS OUYANG,W.X. DEP GYNECOL & OBSTET UNION HOSPITAL TONGJI MEDICAL COLLEGE HUAZHONG UNIV SCIE TECH.
M.D. Browning, M.D. ‘77.  Most Common Cancer of Female Reproductive System  60,000/year with 10,000 deaths  Normal Cells in the Endometrium.
Alternatives to Hysterectomy
Endometriosis *Is the presence of endometrial glands and stroma outside the endometrial cavity and walls *Deposits proliferate during the menstrual cycle,
Malignant disease of the body of the uterus
UTERINE LEIOMYOMA AND NEOPLASIA
Changes before the change: Perimenopausal Bleeding
Functional and symptomatic abnormal uterine bleeding
Endometrial hyperplasia
Post Menopausal Bleeding
ENDOMETRIOSIS.
LEIOMYOMA (Fibroid) Case + Video
ENDOMETRIAL HYPERPLASIA
Male and Female Reproductive Health Concerns
Malignant disease of the body of the uterus
Body Systems and Disorders
Dr. Aya M. Serry Abnormal Uterine Bleeding (AUB) 2016
Changes before the change: Perimenopausal Bleeding
Abnormal uterine bleeding
Uterine cancer Uterine mesenchymal neoplasms
Dr Fulufhelo Tshivhula Specialist Gynaecologist Polokwane
Changes before the change: Perimenopausal Bleeding
Uterine Leiomyomas. Uterine Leiomyomas Most common benign uterine tumors Location :uterus ,cervix ,broad ligament Subserosal Intramural Submucosal.
Female Sexual Anatomy and Physiology
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Chapter 26 Copyright © 2016 F.A. Davis Company.
Fibromyomas of the uterus
ENDOMETRIAL CARCINOMA
Endometriosis Dr Fulufhelo Tshivhula Specialist Gynaecologist
Practical histopathology
Presentation transcript:

Reproductive Blueprint PANCE Blueprint

Uterus Dysfunctional Uterine Bleeding (DUB)- DUB is defined as irregular uterine bleeding not due to anatomic lesions in the uterus DUB is usually due to anovulation due to polycystic ovarian disease, exogenous obesity or adrenal  hyperplasia Females with DUB have irregular often heavy uterine bleeding Women with DUB have chronic estrus.  They have non regular estrogen concentrations that stimulate growth and development of the endometrium

Dysfunction Uterine Bleeding When there is no predictable effect of ovulation, there is no progesterone induced changes With DUB the endometrium thickens and outgrows its blood supply and sloughs off causing irregular heavy bleeding that is not predictable If there is chronic stimulation of the uterine lining form low blood estrogen, the episodes of DUB are infrequent and light. When there is chronic stimulation from high levels of estrogen, the episodes of DUB are heavy and happen often Midcycle spotting can happen with ovulation and usually is self limited attributed to the sudden drop of estrogen

Dysfunctional Uterine Bleeding Before a diagnosis of DUB is made, need to rule out structural causes such as uterine leiomyomata, infection or inflammation of the genital tract, cervical cancer, endometrial cancer, cervical erosions, cervical polyps, and lesion in the vagina. Complications of DUB include blood loss, endometrial hyperplasia that can lead to carcinoma, and incapacitating everyday living One treatment of DUB includes treatment with high dose progesterone for at least 10 day trying to thin the endometrial strip with withdrawal bleeding. Another alternative is administration of contraceptives to establish a regular withdrawal cycle in an effort to make it predictable If medical treatment fails, may need a D and C

Endometrial Cancer Endometrial Hyperplasia is the abnormal proliferation of both glandular and stromal elements showing altered histologic architecture Endometrial proliferation is an overabundance of endometrial whereas endometrial hyperplasia involves the structural elements. Different types of endometrial hyperplasia include cystic glandular hyperplasia, adenomatous hyperplasia, and atypical adenomatous hyperplasia

Endometrial Cancer Important concept is with continued estrogen stimulation through either endogenous or exogenous sources simple endometrial proliferation will lead to endometrial hyperplasia Risk factors for endometrial hyperplasia and endometrial carcinoma are anything that lead to an increase in estrogen in the environment. Diagnosis of endometrial hyperplasia or carcinoma is made by taking a sample.  Common ways to accomplish this are endometrial biopsy, D and C, or by removing of the uterus. The most common indication for endometrial sampling is abnormal bleeding especially those that are over 35.

Endometrial Cancer Most endometrial polyps are focal accentuated benign hyperplastic processes. Estrogen is implicated in antecedent hyperplasia; however, the actual stimulus to malignant degeneration to endometrial carcinoma is unclear Endometrial carcinoma usually occurs in women that are post menopausal Most primary endometrial carcinomas are adenocarcinomas

Endometrial Cancer Special consideration for endometrial sampling should be given to those with post menopausal bleeding that occurs after at least 6 months of amenorrhea. Endometrial carcinoma usually spreads throughout the endometrial cavity first and then begins to invade the myometrium, endocervical canal and eventually the lymphatics Once there is extrauterine spread to the abdominal and pelvic cavity, the spread can be similar to ovarian cancer Common histologic subtypes on endometrial carcinoma include:  papillary serous adenocarcinoma and clear cell adenocarcinoma The biggest prognostic factors is the histologic grade of endometrial cancer (Grading System is G1-G3)

Endometrial Cancer Surgical treatment is the cornerstone of therapy for endometrial carcinoma.  The abdomen pelvic cavity is explored and a TAHSO is performed Adjunctive therapy may include external beam radiation to reduce reoccurrence The first line treatment of recurrent disease is hormonal and includes progesterone at high doses. Chemotherapy is also used

Endometriosis Endometriosis is the presence of endometrial tissue at extrauterine locations Endometriosis typical presents with complaints of infertility, dysmenorrhea, dyspareunia, and chronic pelvic pain The definitive diagnosis of endometriosis requires histologic confirmation at the time of laparoscopy

Endometriosis Different approaches to different patients in treatment Women in late 40's with mild symptoms may just observe to wait on menopause because the decrease in hormones will not stimulate growth of disease Medical therapy is aimed at inducing inactivity of endometrial tissue.  Progestins alone have been administered orally and parenterally Danazol, a 17 alpha ethinyl testosterone derivative, suppresses both LH and FSH so this suppresses estrogen which does not allow the

Endometriosis GnRH Agonist such as leupronlide injections suppresses LH and FSH which suppresses estrogen Surgical therapy is either conservative or extirpative Conservative surgery includes excision, cauterization, or ablation of visible endometriosis and preserving the uterus Definitive surgery includes TAHBSO, lysis of adhesions, and removal os endometriosis

Leiomyoma Leiomyoma are benign uterine growths that are also referred to as fibroids or myomas Leiomyomas the majority of time produce mild symptoms, but despite this it it the most common indication for a hysterectomy The most common symptoms of leiomyoma are pain, secondary dysmenorrhea, menorrhagia, pressure symptoms in the pelvis Leiomyomas are considered hormonally responsive tumors related to estrogen production

Leiomyoma 0.1-1% of the cases of leiomyoma develop malignancy called leiomyosarcoma Diagnosis of leiomyoma is based on clinical exam, bimanual examination, or imaging studies The majority of patients with leiomyoma do not require surgery.  The endometrial tissue can by biopsied and endometrial cancer or hyperplasia can be ruled out Can use prostaglandin inhibitors (NSAIDS) to minimize uterine bleeding and also can use intermittent progestin supplementation.  Considered a conservative approach and can be attempted especially if menopause in eminent

Leiomyoma Surgical treatment can include myomectomy if considering having further children or hysterectomy GnRH analogs can be used for suppression of estrogen

Uterine Prolapse Uterine prolapse is when the pelvic muscles laxity cause downward displacement of the uterus First degree uterine prolapse is when descent is limited to the upper two thirds of the vagina Second degree uterine prolapse is when the uterine structure approaches the vaginal introits Third degree uterine prolapse is descent of the uterine structure outside of the vagina

Uterine Prolapse Non surgical treatment includes support through pessaries and kegel exercises and strengthening pelvic muscles Surgical treatment involves repair of tissue defects Estrogen replacement can also be an adjunct in post menopausal women in the appropriate patients